112 related articles for article (PubMed ID: 9177672)
1. CYP2D6, NAT2 and CYP2E1 genetic polymorphisms in nonagenarians.
Agúndez JA; Rodríguez I; Olivera M; Ladero JM; García MA; Ribera JM; Benítez J
Age Ageing; 1997 Mar; 26(2):147-51. PubMed ID: 9177672
[TBL] [Abstract][Full Text] [Related]
2. Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma.
Khedhaier A; Hassen E; Bouaouina N; Gabbouj S; Ahmed SB; Chouchane L
BMC Cancer; 2008 Apr; 8():109. PubMed ID: 18423013
[TBL] [Abstract][Full Text] [Related]
3. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between human longevity and genetic polymorphisms in drug-metabolizing enzymes at the NAT2, GSTM1 and CYP2D6 loci.
Muiras ML; Verasdonck P; Cottet F; Schächter F
Hum Genet; 1998 May; 102(5):526-32. PubMed ID: 9654200
[TBL] [Abstract][Full Text] [Related]
5. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
Suzuki S; Muroishi Y; Nakanishi I; Oda Y
J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
[TBL] [Abstract][Full Text] [Related]
6. Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolizers.
Agúndez JA; Olivera M; Ladero JM; Rodriguez-Lescure A; Ledesma MC; Diaz-Rubio M; Meyer UA; Benítez J
Pharmacogenetics; 1996 Dec; 6(6):501-12. PubMed ID: 9014199
[TBL] [Abstract][Full Text] [Related]
7. N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.
Mishra S; Daschakraborty S; Shukla P; Kapoor P; Aggarwal R
Natl Med J India; 2013; 26(5):260-5. PubMed ID: 25017831
[TBL] [Abstract][Full Text] [Related]
8. Expression in human prostate of drug- and carcinogen-metabolizing enzymes: association with prostate cancer risk.
Agúndez JA; Martínez C; Olivera M; Gallardo L; Ladero JM; Rosado C; Prados J; Rodriguez-Molina J; Resel L; Benítez J
Br J Cancer; 1998 Nov; 78(10):1361-7. PubMed ID: 9823980
[TBL] [Abstract][Full Text] [Related]
9. Association of CYP2E1 and NAT2 gene polymorphisms with chronic obstructive pulmonary disease.
Arif E; Vibhuti A; Alam P; Deepak D; Singh B; Athar M; Pasha MA
Clin Chim Acta; 2007 Jul; 382(1-2):37-42. PubMed ID: 17442289
[TBL] [Abstract][Full Text] [Related]
10. Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity.
Singla N; Gupta D; Birbian N; Singh J
Tuberculosis (Edinb); 2014 May; 94(3):293-8. PubMed ID: 24637014
[TBL] [Abstract][Full Text] [Related]
11. Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India.
Gupta VH; Amarapurkar DN; Singh M; Sasi P; Joshi JM; Baijal R; Ramegowda PH; Amarapurkar AD; Joshi K; Wangikar PP
J Gastroenterol Hepatol; 2013 Aug; 28(8):1368-74. PubMed ID: 23875638
[TBL] [Abstract][Full Text] [Related]
12. Role of polymorphic CYP2E1 and CYP2D6 genes in NNK-induced chromosome aberrations in cultured human lymphocytes.
Abdel-Rahman SZ; Salama SA; Au WW; Hamada FA
Pharmacogenetics; 2000 Apr; 10(3):239-49. PubMed ID: 10803680
[TBL] [Abstract][Full Text] [Related]
13. [Genetic and phenotypic polymorphisms in carcinogen-metabolizing enzymes and cancer susceptibility].
Watanabe M
Nihon Rinsho; 1996 Aug; 54(8):2261-75. PubMed ID: 8810806
[TBL] [Abstract][Full Text] [Related]
14. Influence of genetic admixture on polymorphisms of drug-metabolizing enzymes: analyses of mutations on NAT2 and C gamma P2E1 genes in a mixed Hispanic population.
Martínez C; Agúndez JA; Olivera M; Llerena A; Ramirez R; Hernández M; Benítez J
Clin Pharmacol Ther; 1998 Jun; 63(6):623-8. PubMed ID: 9663176
[TBL] [Abstract][Full Text] [Related]
15. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
16. [Detoxication gene polymorphism and susceptibility to sporadic motor neuron disease in Russian population].
Skvortsova VI; Slominskiĭ PA; Shadrina MI; Levitskiĭ GN; Levitskaia NI; Alekhin AV; Zherebtsova AL; Serdiuk AV; Limborskaia SA
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(1):4-13. PubMed ID: 16459354
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 (CYP450,2D6*A), N-Acetyltransferase-2 (NAT2*7, A) and Multidrug Resistance 1 (MDR1 3435 T) Alleles Collectively Increase Risk of Ulcerative Colitis.
Lotfi F; Bahrehmand F; Vaisi-Raygani A; Khodarahmi R; Tanhapour M; Kiani A; Rahimi Z; Pourmotabbed T
Arch Iran Med; 2018 Nov; 21(11):530-535. PubMed ID: 30551694
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the human cytochrome P450 and arylamine N-acetyltransferase: susceptibility to head and neck cancers.
Khlifi R; Messaoud O; Rebai A; Hamza-Chaffai A
Biomed Res Int; 2013; 2013():582768. PubMed ID: 24151610
[TBL] [Abstract][Full Text] [Related]
19. Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis.
Bose PD; Sarma MP; Medhi S; Das BC; Husain SA; Kar P
J Gastroenterol Hepatol; 2011 Feb; 26(2):312-8. PubMed ID: 21261721
[TBL] [Abstract][Full Text] [Related]
20. Distribution of allelic and genotypic frequencies of NAT2 and CYP2E1 variants in Moroccan population.
Guaoua S; Ratbi I; Laarabi FZ; Elalaoui SC; Jaouad IC; Barkat A; Sefiani A
BMC Genet; 2014 Dec; 15():156. PubMed ID: 25544508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
